Urology
Volume 75, Issue 2 , Pages 315-320 , February 2010

A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma

  • Claudio Jeldres

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, University of Montréal, Montreal, Canada
    • ,
  • Maxine Sun

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • ,
  • Hendrik Isbarn

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Giovanni Lughezzani

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, Vita-Salute San Raffaele, Milan, Italy
    • ,
  • Lars Budäus

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Ahmed Alasker

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, University of Montréal, Montreal, Canada
    • ,
  • Shahrohk F. Shariat

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • Jean-Baptiste Lattouf

      Affiliations

    • Department of Urology, University of Montréal, Montreal, Canada
    • ,
  • Hugues Widmer

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • ,
  • Daniel Pharand

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • ,
  • Philippe Arjane

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • ,
  • Markus Graefen

      Affiliations

    • Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Francesco Montorsi

      Affiliations

    • Department of Urology, Vita-Salute San Raffaele, Milan, Italy
    • ,
  • Paul Perrotte

      Affiliations

    • Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
    • ,
  • Pierre I. Karakiewicz

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montreal, Quebec, Canada
    • Department of Urology, University of Montréal, Montreal, Canada
    • Corresponding Author InformationReprint requests: Pierre I. Karakiewicz, M.D., F.R.C.S.C., Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center (CHUM), 1058, Rue St-Denis, Montréal, QC, Canada, H2X 3J4

Received 17 July 2009 ,Accepted 4 October 2009.

References 

  1. Oosterlinck W, Solsona E, van der Meijden AP, et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol. 2004;46:147–154
  2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–1233
  3. Koukourakis G, Zacharias G, Koukourakis M, et al. Comprehensive management of upper tract urothelial carcinoma. Adv Urol, in press.
  4. Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 2007;4:432–443
  5. Taweemonkongsap T, Nualyong C, Amornvesukit T, et al. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. World J Surg Oncol. 2008;6:3
  6. Halachmi S, Katz Y, Meretyk S, et al. Perioperative morbidity and mortality in 80 years and older undergoing elective Urology Surgery—a prospective study. Aging Male. 2008;162–166
  7. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int. 2009;103:307–311
  8. Cloutier V, Capitanio U, Zini L, et al. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur Urol, in press.
  9. Isbarn H, Jeldres C, Zini L, et al. A population-based assessment of perioperative mortality after cysectomy for bladder cancer. J Urol. 2009;182(1):70–77
  10. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117–1121
  11. Surveillance Epidemiology and End Results Surveillance Program, Surveillance Research Program: SEER Program (1973-2006): National Cancer Institute, DCCPS, Cancer Statistics Branch, released 2009.
  12. Van Houwelingen JC, Le Cessie S. Predictive value of statistical models. Stat Med. 1990;9:1303–1325
  13. Atkinson AC. A note on the generalized information criterion for choice of a model. Biometrika. 1980;67:413–418
  14. Liguori G, Trombetta C, Pomara G, et al. Major invasive surgery for urologic cancer in octogenarians with comorbid medical conditions. Eur Urol. 2007;51:1600–1604
  15. Zini L, Cloutier V, Isbarn H, et al. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Clin Cancer Res. 2009;15:1013–1018
  16. Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007;25:3576–3581
  17. Walz J, Montorsi F, Jeldres C, et al. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases. BJU Int. 2008;101:826–832
  18. Bochner BH, Kattan MW, Vora KC International Bladder Cancer Nomogram Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24:3967–3972
  19. Karakiewicz PI, Suardi N, Capitanio U, et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol. 2008;55(2):287–295
  20. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612–618
  21. Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53:794–802
  22. Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007;25:1316–1322
  23. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006;12:6663–6676
  24. Slovin SF, Wilton AS, Heller G, et al. Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy. Clin Cancer Res. 2005;11:8669–8673
  25. Smaletz O, Scher HI, Small EJ, et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol. 2002;20:3972–3982
  26. Halabi S, Small EJ, Kantoff PW, et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003;21:1232–1237
  27. Wong SL, Kattan MW, McMasters KM, et al. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol. 2005;12:282–288
  28. Hiroyoshi S, Akira K, Naoto K, et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology. 2006;67:131–136

 Pierre I. Karakiewicz is partially supported by the University of Montréal Health Center Urology Associates, Fonds de la Recherche en Santé du Quebec, the University of Montréal Department of Surgery and the University of Montréal Health Center (CHUM) Foundation.

 Claudio Jeldres and Maxine Sun have contributed equally for the preparation of this manuscript.

PII: S0090-4295(09)02703-4

doi: 10.1016/j.urology.2009.10.004

Urology
Volume 75, Issue 2 , Pages 315-320 , February 2010

Article Tools

* Image Usage & Resolution